PKPD Exam 3 Flashcards

1
Q

bioavailability of digoxin tablets

A

f = 0.7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

bioavailability of digoxin elixir

A

f = 0.8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

bioavailability of digoxin lanoxicaps

A

f = 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

average volume of digoxin

A

7.3 L/kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

therapeutic range (css,av) for digoxin

A

0.5-2.0 ng/mL (mcg/L)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

why is pk optimization needed for digoxin

A

-high interpatient variability in disposition
-low TI
-poor accuracy in predicting PK parameters from patient characteristics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

after how many hours are collected digoxin concentrations considered the Css,av concentration

A

6 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the specific activity of anti-digoxin immune fab

A

0.8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

why is there a maximum infusion rate for phenytoin sodium

A

avoid hypotension due to cardiac suppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the water soluble ester prodrug of phenytoin that avoids injection problems and can be administered more rapidly

A

fosphenytoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

why is IM phenytoin sodium not recommended

A

some precipitates resulting in prolonged erratic absorption, painful

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

phenytoin is a weak acid with limited water solubility, so absorption is…..

A

slow, peaks delayed several hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

phenytoin is primarily bound to

A

albumin in the plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

concentrations of phenytoin needed to be adjusted to account for

A

altered protein binding
ESRD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

which drug displaces phenytoin from plasma albumin and needs to be considered to adjust concentration

A

valproate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how is phenytoin primarily cleared

A

hepatic metabolism by CYP2C9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what type of PK does phenytoin follow

A

nonlinear–> number of drug saturates the enzymes ability to metabolize the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

therapeutic range of phenytoin

A

10-20 mg/L of total phenytoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is the Vd of phenytoin (estimated before data)

A

0.65 L/kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is the Vmax of phenytoin (estimated before data)

A

7 mg/kg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what is the Km of phenytoin (for estimation before data, or when 1 dosing regimen is available)

22
Q

what is the absorption of carbamazepine

A

-rate varies between dosage forms
-may have saturable absorption, high doses may have reduced F
-IR- slow, erratic, unpredictable due to slow dissolution (secondary peaks may occur)

23
Q

should IR or ER carbamazepine be taken with food

A

IR & ER tabs– yes
ER caps– with or without

24
Q

distribution of carbamazepine

A

rapid and uniform
binds to albumin and AAG

25
how is carbamazepine primarily cleared
hepatic metabolism by CYP3A4
26
what DDIs are carbamazepine responsible for
potent enzyme inducer- enhances metabolism of many drugs
27
carbamazepine is an autoinducer, so it...
induces its own metabolism
28
what is the therapeutic range of carbamazepine
4-12 mg/L
29
what concentration of carbamazepine is associated with AEs
>15 mg/L
30
how is dosing initiated in carbamazepine
-start at 1/4 to 1/3 of the desired maintenance dose -increase by a similar amount ever 2-3 weeks until desired dose reached
31
when can therapeutic effect and steady state be assessed in carbamazepine
2-3 weeks after final dosing increase
32
what is the benefit of gradual exposure of carbamazepine
-tolerance of AEs -allows liver enzyme induction and CL increases to occur over the 6-12 week period
33
absorption of valproic acid
rate depends on dosage form, delay may be 1-6 hours
34
how does food affect absorption of valproic acid
can decrease the rate of absorption time to achieve peak may be delayed 3-8 hours
35
what is the distribution of valproic acid
Vd is relatively small
36
what is valproic acid bound to? is it saturable
highly bound to albumin, binding is saturable
37
how is valproic acid cleared
primarily eliminated by the liver
38
what concentration dependent change occurs with valproic acid? what does this reflect
CL --> higher CL at higher concentrations higher CL may reflect saturable protein binding
39
what DDIs is valproic acid responsible for
enzyme inhibitor subject to enzyme induction
40
what is the target concentration of valproic acid
minimum trough: 40-50 mg/L seizure control improves with trough: 40-120 mg/L some may tolerate and benefit from >120 mg/L
41
what is the typical maintenance dose of valproic acid
15 mg/kg/day
42
what is the density of ethanol
0.78924 g/mL
43
how is BAC provided
%w/v (g/dL)
44
alcohol contents of beer
5% v/v 18mL/355mL
45
alcohol contents of wine
12% 18mL/150mL
46
alcohol contents of distilled beverages
40% 12mL/30mL
47
how is gastric emptying affected by high concentrations of EtOH? how does this affect absorption?
gastric emptying inhibited by high concentrations complete absorption may require 2-6h
48
what is distribution of ethanol
very rapid, V ~ V of total body water (0.6L/kg)
49
how is ethanol primarily metabolized
oxidized metabolized to acetylaldehyde by alcohol dehydrogenase, then further metabolized to acetyl CoA
50
what type of PK does ethanol follow
nonlinear --> elimination is saturable